Table 5

Receiver operating characteristic curve analyses predicting the presence of mPAP >35mm Hg

 Positive predictive valueNegative predictive value
Paw scoresAUCAUC's SEp ValueSensitivitySpecificity5% prev13% prev5% prev13% prev
40 patients
 %CSA<5+PaO2+WT0.7900.073<0.0010.7500.7000.1160.2720.9820.949
(0.615 to 0.884)(0.557 to 0.842)(0.016 to 0.215)(0.134 to 0.409)(0.940 to 1.000)(0.880 to 1.000)
 %CSA<5+PaO20.7960.0690.0040.7000.8000.1560.3430.9810.947
(0.557 to 0.842)(0.676 to 0.923)(0.043 to 0.268)(0.195 to 0.490)(0.938 to 1.000)(0.877 to 1.000)
 %CSA<5+WT0.7410.0790.0020.6500.8000.1460.3270.9770.939
(0.502 to 0.797)(0.676 to 0.923)(0.036 to 0.255)(0.181 to 0.472)(0.930 to 1.000)(0.864 to 1.000)
 PaO2+WT0.6510.0860.077NDNDNDNDNDND
105 patients
 %CSA<5+PaO2+WT0.8280.050<0.0010.7500.8000.1650.3590.9840.955
(0.667 to 0.832)(0.723 to 0.876)(0.094 to 0.235)(0.267 to 0.450)(0.959 to 1.000)(0.915 to 0.994)
 %CSA<5+PaO20.8390.043<0.0010.9500.5380.0380.2350.9950.986
(0.908 to 0.991)(0.442 to 0.663)(0.001 to 0.074)(0.153 to 0.316)(0.981 to 1.000)(0.963 to 1.000)
 %CSA<5+WT0.7650.060<0.0010.6500.8250.1640.3570.9780.940
(0.558 to 0.741)(0.752 to 0.897)(0.093 to 0.234)(0.265 to 0.448)(0.949 to 1.000)(0.894 to 0.985)
 PaO2+WT0.7380.056<0.0010.7500.6130.0920.2240.9790.943
(0.667 to 0.832)(0.519 to 0.706)(0.036 to 0.147)(0.144 to 0.303)(0.951 to 1.000)(0.898 to 0.987)
  • Data are absolute number with 95% CI.

  • AUC, area under curve; %CSA<5, percentage of total lung area taken up by the cross-sectional area of pulmonary vessels less than 5 mm2; mPAP, mean pulmonary arterial pressure; ND, not determined; PaO2, oxygen arterial partial pressure (mm Hg); prev, prevalence of severe PH in the COPD population; WT, mean wall thickness (mm).